# Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

> **NCT02036554** · PHASE4 · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 234 (estimated)

## Conditions studied

- Kidney; Complications, Allograft

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolic acid

## Key facts

- **NCT ID:** NCT02036554
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2014-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036554, "Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02036554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*